Literature DB >> 31463955

Interobserver agreement and diagnostic accuracy of shearwave elastography for the staging of hepatitis C virus-associated liver fibrosis.

Pál N Kaposi1, Zsuzsanna Unger1, Bence Fejér1, András Kucsa1, Ambrus Tóth1, Anikó Folhoffer2, Ferenc Szalay2, Viktor Bérczi1.   

Abstract

PURPOSE: Our study aimed to evaluate the technical success rate, interobserver reproducibility, and accuracy of shearwave elastography (SWE) in the staging of hepatitis C virus (HCV)-associated liver fibrosis.
METHODS: A total of 10 healthy controls and 49 patients with chronic liver disease were enrolled prospectively. Two examiners performed point shearwave elastography (pSWE) and two-dimensional shearwave elastography (2D-SWE) measurements with an RS85A ultrasound scanner using the S-Shearwave application (Samsung Medison, Hongcheon, Korea). The performance of S-Shearwave in the staging (METAVIR F0-F4) of liver fibrosis was compared with prior transient elastography (TE) with receiver operating characteristic (ROC) curve analysis.
RESULTS: The interobserver reproducibility was excellent with pSWE (ICC = 0.92, 95% CI: 0.86-0.95, P < .001). A very good agreement was found between pSWE and TE measurements (ICC =0.85, 95% CI: 0.78-0.89, P < .001). The ROC analysis determined the optimal cut-off values of pSWE for the staging of chronic hepatitis C-associated fibrosis (F2, 1.46 m/s; F3, 1.63 m/s; F4, 1.95 m/s). Both observers achieved excellent diagnostic accuracy (AUROC: 94% vs 97%) in the detection of significant (≥F2) liver fibrosis.
CONCLUSION: The interobserver agreement is excellent with S-Shearwave pSWE, and observers can diagnose significant liver fibrosis with a comparable accuracy to TE.
© 2019 The Authors. Journal of Clinical Ultrasound published by Wiley Periodicals, Inc.

Entities:  

Keywords:  HCV; chronic hepatitis C; liver fibrosis; shearwave elastography

Mesh:

Year:  2019        PMID: 31463955     DOI: 10.1002/jcu.22771

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  4 in total

1.  Tissue attenuation imaging and tissue scatter imaging for quantitative ultrasound evaluation of hepatic steatosis.

Authors:  Aladár D Rónaszéki; Bettina K Budai; Barbara Csongrády; Róbert Stollmayer; Krisztina Hagymási; Klára Werling; Tamás Fodor; Anikó Folhoffer; Ildikó Kalina; Gabriella Győri; Pál Maurovich-Horvat; Pál N Kaposi
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

2.  Staging liver fibrosis after severe yellow fever with ultrasound elastography in Brazil: A six-month follow-up study.

Authors:  Yuri Costa Sarno Neves; Victor Augusto Camarinha de Castro-Lima; Davi Jorge Fontoura Solla; Vivian Simone de Medeiros Ogata; Fernando Linhares Pereira; Jordana Machado Araujo; Ana Catharina Seixas Nastri; Yeh-Li Ho; Maria Cristina Chammas
Journal:  PLoS Negl Trop Dis       Date:  2021-07-20

3.  A non-invasive test that enables longitudinal monitoring of chronic liver disease: VCTE versus 2D-SWE.

Authors:  Hyunwoo Oh
Journal:  Korean J Intern Med       Date:  2022-02-28       Impact factor: 2.884

4.  Clinical relevance of shear wave elastography compared with transient elastography and other markers of liver fibrosis.

Authors:  Oyekoya T Ayonrinde; Marilyn Zelesco; Christopher J Welman; Steven Abbott; Niwansa Adris
Journal:  Intern Med J       Date:  2022-03-10       Impact factor: 2.611

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.